6-143471538-T-C
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_003630.3(PEX3):c.524-19T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.392 in 1,598,930 control chromosomes in the GnomAD database, including 125,878 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.37 ( 10569 hom., cov: 32)
Exomes 𝑓: 0.40 ( 115309 hom. )
Consequence
PEX3
NM_003630.3 intron
NM_003630.3 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.831
Publications
9 publications found
Genes affected
PEX3 (HGNC:8858): (peroxisomal biogenesis factor 3) The product of this gene is involved in peroxisome biosynthesis and integrity. It assembles membrane vesicles before the matrix proteins are translocated. Peroxins (PEXs) are proteins that are essential for the assembly of functional peroxisomes. The peroxisome biogenesis disorders (PBDs) are a group of genetically heterogeneous autosomal recessive, lethal diseases characterized by multiple defects in peroxisome function. The peroxisomal biogenesis disorders are a heterogeneous group with at least 14 complementation groups and with more than 1 phenotype being observed in cases falling into particular complementation groups. Although the clinical features of PBD patients vary, cells from all PBD patients exhibit a defect in the import of one or more classes of peroxisomal matrix proteins into the organelle. Defects in this gene are a cause Zellweger syndrome (ZWS). [provided by RefSeq, Oct 2008]
PEX3 Gene-Disease associations (from GenCC):
- peroxisome biogenesis disorderInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- peroxisome biogenesis disorder 10A (Zellweger)Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
- peroxisome biogenesis disorder 10BInheritance: AR Classification: STRONG Submitted by: G2P
- Zellweger spectrum disordersInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BP6
Variant 6-143471538-T-C is Benign according to our data. Variant chr6-143471538-T-C is described in ClinVar as Benign. ClinVar VariationId is 259107.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.446 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.366 AC: 55650AN: 151862Hom.: 10562 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
55650
AN:
151862
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.379 AC: 94969AN: 250842 AF XY: 0.373 show subpopulations
GnomAD2 exomes
AF:
AC:
94969
AN:
250842
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.395 AC: 571886AN: 1446952Hom.: 115309 Cov.: 30 AF XY: 0.392 AC XY: 282395AN XY: 720704 show subpopulations
GnomAD4 exome
AF:
AC:
571886
AN:
1446952
Hom.:
Cov.:
30
AF XY:
AC XY:
282395
AN XY:
720704
show subpopulations
African (AFR)
AF:
AC:
8603
AN:
33196
American (AMR)
AF:
AC:
20456
AN:
44668
Ashkenazi Jewish (ASJ)
AF:
AC:
9322
AN:
26000
East Asian (EAS)
AF:
AC:
13828
AN:
39520
South Asian (SAS)
AF:
AC:
21822
AN:
85748
European-Finnish (FIN)
AF:
AC:
18768
AN:
53320
Middle Eastern (MID)
AF:
AC:
2323
AN:
5646
European-Non Finnish (NFE)
AF:
AC:
454111
AN:
1099018
Other (OTH)
AF:
AC:
22653
AN:
59836
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.469
Heterozygous variant carriers
0
15574
31147
46721
62294
77868
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
13706
27412
41118
54824
68530
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.366 AC: 55672AN: 151978Hom.: 10569 Cov.: 32 AF XY: 0.364 AC XY: 27019AN XY: 74308 show subpopulations
GnomAD4 genome
AF:
AC:
55672
AN:
151978
Hom.:
Cov.:
32
AF XY:
AC XY:
27019
AN XY:
74308
show subpopulations
African (AFR)
AF:
AC:
11120
AN:
41466
American (AMR)
AF:
AC:
6953
AN:
15276
Ashkenazi Jewish (ASJ)
AF:
AC:
1204
AN:
3470
East Asian (EAS)
AF:
AC:
1748
AN:
5172
South Asian (SAS)
AF:
AC:
1218
AN:
4818
European-Finnish (FIN)
AF:
AC:
3564
AN:
10560
Middle Eastern (MID)
AF:
AC:
109
AN:
294
European-Non Finnish (NFE)
AF:
AC:
28432
AN:
67912
Other (OTH)
AF:
AC:
819
AN:
2100
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1799
3598
5396
7195
8994
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
542
1084
1626
2168
2710
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
993
AN:
3474
ClinVar
Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Aug 07, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Oct 21, 2015
Mayo Clinic Laboratories, Mayo Clinic
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Peroxisome biogenesis disorder 10B Benign:1
Sep 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Peroxisome biogenesis disorder 10A (Zellweger) Benign:1
Sep 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.